ABSTRACT
Objective Mood disorder (including major depression and bipolar disorder) prevalence is over 10% and accounts for a significant share of global disease burden. Mental and physical illness are related, however, the association between mood disorders and acute/chronic disease subclasses remains poorly understood.
Methods This observational cross-sectional study used administrative claims data from 6,709,258 adult enrollees with a full-year enrollment in the 2018 OPTUM Clinformatics® database. Data of enrollees with/without diagnoses of a mood disorder co-occurring with chronic comorbid conditions (defined by the Elixhauser Comorbidity Index) using the International Classification of Diseases (ICD-10) were analyzed by accounting for age, race, and ethnicity.
Results Overall, the sample was predominantly non-Hispanic Caucasians (64.56%), with 48.59% females and a mean age of 43.54 years±12.46 years. The prevalence of mood disorders was 3.71% (248,890), of which 0.61% (n=40,616) had bipolar disorders and 3.10% (n=208,274) had Major Depressive Disorder (MDD). Logistic regression odds ratios revealed a strong association between mood disorder diagnoses and peptic ulcers (2.11; CI=2.01-2.21), weight loss (2.53; CI, 2.46-2.61), renal failure (2.37, CI = 2.31-2.42), peripheral vascular disease (2.24; CI=2.19-2.30), and pulmonary circulation disorder (1.77; CI=1.70-1.84).
Conclusions Overall, mood disorders were associated with vascular and cardiac chronic medical conditions, suggesting a possible pathophysiological link between these conditions. The results highlight the importance of understanding the prevalence of co-occurring mood and medical conditions and may inform novel biological diagnostics and future identification of mechanisms for multimorbidity.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the UTHealth Houston Institutional Review Board.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Conflicts of Interest and Source of Funding: None to disclose.
Data Availability
Data will be made available upon request to the UTHEalth Houston Data Center.